Hostname: page-component-7c8c6479df-ws8qp Total loading time: 0 Render date: 2024-03-29T05:31:31.389Z Has data issue: false hasContentIssue false

Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance

Published online by Cambridge University Press:  16 November 2004

S. J. CONATY
Affiliation:
Centre for Infectious Diseases Epidemiology, Department of Primary Care and Population Science, University College London, UK
A. C. HAYWARD
Affiliation:
Centre for Infectious Diseases Epidemiology, Department of Primary Care and Population Science, University College London, UK
A. STORY
Affiliation:
Communicable Disease Surveillance Centre, Health Protection Agency, Colindale, London, UK
J. R. GLYNN
Affiliation:
Infectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK
F. A. DROBNIEWSKI
Affiliation:
Mycobacterium Reference Unit, Public Health Laboratory Service, Health Protection Agency, Dulwich, UK
J. M. WATSON
Affiliation:
Communicable Disease Surveillance Centre, Health Protection Agency, Colindale, London, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Drug-resistant tuberculosis can be transmitted (primary) or develop during the course of treatment (secondary). We investigated risk factors for each type of resistance. We compared all patients in England and Wales with isoniazid- and multidrug-resistant tuberculosis in two time-periods (1993–1994 and 1998–2000) with patients with fully sensitive tuberculosis, examining separately patients without and with previous tuberculosis (a proxy for primary and secondary drug-resistant tuberculosis). Patients with previous tuberculosis smear positivity and arrival in the United Kingdom <5 years were strongly associated with multidrug resistance and isoniazid resistance. In patients with no previous tuberculosis HIV infection, residence in London and foreign birth were risk factors for multidrug resistance, and non-white ethnicity, residence in London and HIV infection for isoniazid resistance. Risk factors for each type of resistance differ. Elevated risks associated with London residence, HIV positivity, and ethnicity were mainly seen in those without previous tuberculosis (presumed transmission).

Type
Research Article
Copyright
© 2004 Cambridge University Press